Clinical Trial Update: Phase 2 Combination of Melphalan/HDS Via PHP + Tebentafusp in Treating Metastatic Uveal Melanoma [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial is evaluating a combination of melphalan/HDS delivered via PHP with tebentafusp for metastatic uveal melanoma, with recruitment curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveal Melanoma

Drugs mentioned

• KIMMTRAK (tebentafusp)
• Melphalan (Melphalan)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Metastatic Uveal Melanoma | Phase 2 | Status: RECRUITING